A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone
This study has been completed.
Sponsor:
ActivX Biosciences, Inc.
Collaborator:
Kyorin Pharmaceutical Co.,Ltd
Information provided by:
ActivX Biosciences, Inc.
ClinicalTrials.gov Identifier:
NCT00525330
First received: September 3, 2007
Last updated: June 21, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | August 2008 |
| Primary Completion Date: | August 2008 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | June 7, 2011 |